在急诊部使用多次纳洛的管理:一个追溯的基于索赔的分析分析
Rachael Rzasa Lynn1, Jeffrey Galinkin2, Monica McClain3
1Department of Anesthesiology, University of Colorado School of Medicine, Aurora, Colorado.
The Journal of emergency medicine
|October 23, 2025
概括
在急诊室 (ED) 使用多次纳洛的使用正在增加,这表明越来越需要有效的阿片类药物过量逆转策略. 这一趋势凸显了监测阿片类药物中毒治疗适度的重要性.
科学领域:
- 紧急医疗 紧急医疗
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 合成阿片类药物,包括芬太尼,是美国阿片类药物过量死亡的主要原因.
- 紧急医疗服务 (EMS) 在阿片类药物过量逆转方面增加了纳洛的管理.
- 美国食品和药物管理局 (FDA) 已批准纳洛广泛使用.
研究的目的:
- 调查紧急部门 (ED) 内多次纳洛管理的趋势.
- 为了确定ED纳洛使用模式是否与EMS中观察到的相似.
- 评估急性护理环境中阿片类药物过量管理的不断变化的格局.
主要方法:
- 基于索赔的回顾性队列研究,使用Merative MarketScan®和国家紧急部门样本 (NEDS) 数据库.
- 计算了在EDs (MarketScan) 和ED访问多次管理 (NEDS) 中接受多次纳洛管理的患者的百分比.
- 分析时间趋势使用科克兰-阿米塔奇测试来评估统计学意义.
主要成果:
- 在MarketScan数据 (2016-2022) 中,纳洛接收者中,多次纳洛的使用量增加了72.8% (从10.1%增加到17.4%).
- 在NEDS数据 (2016-2021年) 中,多次纳洛管理增加了ED访问的146.7% (从3.0%增加到7.3%),其中纳洛被给予.
- 这两组数据都显示了多次纳洛管理的统计学上显著增加 (p < 0.01).
结论:
- 越来越多的急诊室患者因阿片类药物过量而需要多次纳洛.
- 这一趋势需要持续监测纳洛的有效性和治疗方案.
- 目前的治疗选择必须不断评估在管理复杂的阿片类药物中毒病例的充分性.
相关概念视频
Drug Delivery: Enteral Route
1.6K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.6K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
908
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
908
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
249
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
249
Adrenergic Agonists: Therapeutic Uses
1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
232
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
232
Bioequivalence of Drugs: Drugs with Multiple Indications
147
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
147


